MENS Earnings & Financial Statements
Jyong Biotech Ltd. Ordinary Shares
$2.01
-$0.03(-1.47%)
26
Overall
40
Value
20
Tech
18
Quality
Market Cap
$155.10M
Volume
9.09K
52W Range
$1.43 - $63.00
Target Price
--
MENS earnings and financial statements: Jyong Biotech Ltd. Ordinary Shares's income statement, balance sheet and cash flow statement, annual and quarterly.
MENS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating income | -$2.61M | -$2.06M | -$2.80M | -$2.83M |
| EBITDA | -$4.57M | -$3.03M | -$4.27M | - |
| Net income | -$4.67M | -$3.15M | -$4.40M | -$6.63M |
| EPS (diluted) | $-0.06 | $-0.04 | $-0.06 | $-0.09 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $6.37M | $6.37M | $8.25M | $8.74M |
| Total liabilities | $42.88M | $42.88M | $42.32M | $38.38M |
| Shareholders’ equity | -$36.52M | -$36.52M | -$34.07M | -$29.63M |
| Cash and equivalents | $98.0K | $98.0K | $177.0K | $718.0K |
| Long-term debt | $8.66M | $8.66M | $6.35M | $4.48M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$3.04M | -$3.62M | -$2.60M | -$2.97M |
| Free cash flow | -$3.04M | -$3.62M | -$2.60M | -$3.22M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MENS | $2.01 | -1.5% | 9.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Jyong Biotech Ltd. Ordinary Shares Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW